OKYO Pharma Limited (OKYO)

OKYO Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 17, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Cap	75	1	1	1	-	-
Market Cap Growth	-32.25%	-7.90%	15.86%	-	-	-
Enterprise Value	71.01	-0.86	-0.06	-1.17	0	0
Last Close Price	1.43	1.27	1.49	1.68	-	-
PB Ratio	-	-0.13	-0.13	-0.32	-	-
EV/EBITDA Ratio	-	0.11	0.00	0.09	-	-
EV/EBIT Ratio	-	0.11	0.00	0.09	-	-
EV/FCF Ratio	-	0.47	0.01	0.15	-	-
Debt / Equity Ratio	-0.05	0	0	-1.08	0	0
Net Debt / Equity Ratio	1.18	0.28	0.14	0.89	-0.92	-1.29
Net Debt / EBITDA Ratio	0.57	0.20	0.05	0.14	0.44	2.04
Net Debt / FCF Ratio	1.30	0.86	0.09	0.24	0.49	4.26
Quick Ratio	0.58	0.40	0.21	0.72	3.17	4.09
Current Ratio	0.58	0.40	0.21	0.72	3.17	4.09
Return on Equity (ROE)	16.53%	97.72%	450.75%	-2984.50%	-131.37%	-129.97%
Return on Assets (ROA)	-49.11%	-192.78%	-498.85%	-279.20%	-95.33%	-87.21%
Return on Capital Employed (ROCE)	159.13%	139.47%	423.63%	-2965.64%	-149.23%	-128.21%
Buyback Yield / Dilution	-24.46%	-34.57%	-31.84%	-47.74%	-45.55%	-12.98%
Total Shareholder Return	-24.46%	-34.57%	-31.84%	-47.74%	-45.55%	-12.98%

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Jan 30, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 17, 2026

Data Sources Report a data error